8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  August 12, 2013

UNIVERSAL HOSPITAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-20086	41-0760940
(State or other jurisdiction of	(Commissio	(IRS Employer
incorporation)	File Number)	Identification No.)

6625 West 78th Street, Suite 300

Minneapolis, Minnesota 55439-2604

(Address of principal executive offices)

(Zip Code)

952-893-3200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 2.02  RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On August 12, 2013 Universal Hospital Services, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2013.  A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

ITEM 7.01  REGULATION FD DISCLOSURE

Attached as Exhibit 99.2 to this report, and incorporated herein by reference, is a copy of the slide presentation for the investor conference call with management scheduled for August 13, 2013, to discuss Universal Hospital Services, Inc.’s announced results for the quarter ended June 30, 2013.

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS

(d)Exhibits

99.1Press release issued by Universal Hospital Services, Inc. on August 12, 2013

99.2Slides presented during Universal Hospital Services, Inc.’s earnings call scheduled for August 13, 2013 of its results for the quarter ended June 30, 2013

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, Universal Hospital Services, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 12, 2013	UNIVERSAL HOSPITAL SERVICES, INC.
		By	/S/ James B. Pekarek
		James B. Pekarek
		Executive Vice President and
		Chief Financial Officer

3

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press release issued by Universal Hospital Services, Inc. on August 12, 2013
99.2	Slides presented during Universal Hospital Services, Inc.’s earnings call scheduled for August 13, 2013 of its results for the quarter ended June 30, 2013

4

EX-99.1

Exhibit 99.1

Corporate Office
6625 West 78th Street, Suite 300
Minneapolis, MN 55439
Phone: 952.893.3200
Fax: 952.893.0704
www.uhs.com

CONTACT:James Pekarek;

Executive Vice President and Chief Financial Officer

Universal Hospital Services, Inc.

(952) 607-3054

UNIVERSAL HOSPITAL SERVICES, INC. ANNOUNCES 2013 SECOND QUARTER RESULTS

Minneapolis, Minn.—(BUSINESS WIRE)— August 12, 2013 — Universal Hospital Services, Inc. (“UHS”), a leading provider of medical equipment management and service solutions, today announced financial results for the quarter ended June 30, 2013.

Total revenues were $107.0 million for the second quarter of 2013, representing a $0.3 million or 0.3% increase from total revenues of $106.7 million for the same period of 2012.  Revenues for the first six months of 2013 totaled $217.3 million, representing a $6.7 million or 3.2% increase from $210.6 million for same period of 2012.

Second quarter Adjusted EBITDA was $28.5 million, a 3.7% decrease from the prior year when excluding the $12.8 million of recalled equipment gains recognized in the second quarter of 2012.  Adjusted EBITDA for the first six months of 2013 was $60.4 million, a 2.6% decrease from the prior year same period when excluding the $15.4 million of recalled equipment gains recognized in the first six months of 2012.

Conference Call Dial-in Information

UHS will hold its quarterly conference call to discuss 2013 second quarter results on Tuesday, August 13, 2013 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

To participate, call (855) 539-7565 and advise the operator you would like to participate in the UHS Second Quarter 2013 Earnings Conference Call.  A recording of this call will be available from 2:00 p.m. Eastern Time on August 13, 2013 through September 13, 2013 by calling (855) 859-2056; enter conference ID 30156621.

UHS will also use a slide presentation to facilitate the conference call discussion.  A copy of the presentation may be obtained via the company’s website at www.uhs.com in the “Who We Are” section.  From this section, select “Financials” then “Presentations.”

Adjusted EBITDA Reconciliation

Adjusted EBITDA is defined by UHS as Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) before management and board fees, stock option expense, ASC 805 impact, loss on extinguishment of debt and transaction and related costs, which may not be calculated consistently among other companies applying similar reporting measures.  EBITDA and Adjusted EBITDA are not intended to represent an alternative to operating income or cash flows from operating, financing or investing activities (as determined in accordance with generally accepted accounting principles (“GAAP”)) as a measure of performance, and are not representative of funds available for discretionary use due to UHS’ financing obligations.  EBITDA is included because it is a widely accepted financial indicator used by certain investors and financial analysts to assess and compare companies and is an integral part of UHS’ debt covenant calculations.  Adjusted EBITDA is included because UHS’ financial guidance and certain compensation plans are based upon this measure.  Management believes that Adjusted EBITDA provides an important perspective on the company’s ability to service its long-term obligations, the company’s ability to fund continuing growth, and the company’s ability to continue as a going concern.  A reconciliation of consolidated net income (loss) to EBITDA and Adjusted EBITDA is included below.

	2nd Quarter					June YTD						LTM
(In millions)	2013			2012		2013			2012			2013
Net income (loss) attributable to UHS*	$	(12.8	)	$	2.1	$	(23.2	)	$	(1.0	)	$	(57.1	)
Interest expense	13.9			14.5		27.8			30.0			53.5
Provision (benefit) for income taxes	0.2			0.2		0.9			(3.0		)	1.0
Depreciation and amortization	24.7			24.0		48.8			47.6			97.9
EBITDA*	26.0			40.8		54.3			73.6			95.3
Management, board & strategic fees	1.9			0.5		3.3			1.5			4.6
Loss on extinguishment of debt	—			—		1.9			—			14.2
Reorganization costs	0.2			—		0.3			—			7.3
Stock option expense	0.4			1.1		0.6			2.2			2.4
Other ASC 805 Impact	—			—		—			0.1			—
Adjusted EBITDA*	$	28.5		$	42.4	$	60.4		$	77.4		$	123.8

*Includes recall gains of $0.0 and $12.8 for Q2 2013 and 2012, $0.0 and $15.4 for YTD June 2013 and 2012, and $3.2 for LTM 2013.

About Universal Hospital Services, Inc.

Universal Hospital Services, Inc. is a leading nationwide provider of medical equipment management and service solutions to the health care industry. UHS manages more than 680,000 pieces of medical equipment for approximately 8,600 clients in all 50 states. For more than 70 years, UHS has delivered management and service solutions that help clients reduce costs, increase operating efficiencies, improve caregiver satisfaction and support optimal patient outcomes.

Universal Hospital Services, Inc.

6625 West 78th Street, Suite 300

Minneapolis, MN  55439

952-893-3200

www.uhs.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Universal Hospital Services, Inc., believes statements in this presentation looking forward in time involve risks and uncertainties. The following factors, among others, could adversely affect our business, operations and financial condition causing our actual results to differ materially from those expressed in any forward-looking statements: our history of net losses and substantial interest expense; our need for substantial cash to operate and expand our business as planned; our substantial outstanding debt and debt service obligations; restrictions imposed by the terms of our debt; a decrease in the number of patients our customers are serving; our ability to effect change in the manner in which healthcare providers traditionally procure medical equipment; the absence of long-term commitments with customers; our ability to renew contracts with group purchasing organizations and integrated delivery networks; changes in reimbursement rates and policies by third-party payors; the impact of health care reform initiatives; the impact of significant regulation of the health care industry and the need to comply with those regulations; the effect of prolonged negative changes in domestic and global economic conditions; difficulties or delays in our continued expansion into certain of our businesses/geographic markets and developments of new businesses/geographic markets; additional credit risks in increasing business with home care providers and nursing homes, impacts of equipment product recalls or obsolescence; increases in vendor costs that cannot be passed through to our customers; and other Risk Factors as detailed in our annual report on Form 10-K for the year ended December 31, 2012, as well as our other filings with the Securities and Exchange Commission.

EX-99.2

Exhibit 99.2

UHOS Q2 2013 Earnings Teleconference August 13, 2013

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Universal Hospital Services, Inc. believes statements in this presentation looking forward in time involve risks and uncertainties based on management’s current views and assumptions. Actual events may differ materially. Please refer to the cautionary statement regarding forward-looking statements and risk factors that appear in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, and other filings with the SEC, which can be accessed at www.UHS.com under “Financials.” This presentation contains non-GAAP measures as defined by SEC rules. Reconciliations of these measures to the most directly comparable GAAP measures are contained in the appendix. Forward Looking Statements

2013 Results (Adjusted EBITDA) $28.5 $29.6 2012 2013 $28.5 $42.4 $12.8 $120.6 $121.8 2012 2013 $27.0 $123.8 $148.8 $3.2 2nd Quarter Q2 LTM Recall Gains Solid Q1 flu season was offset by weaker hospital volumes in Q2 Planned investments continue to support growth areas

More Focused, Solutions Oriented, Organization

2013 First Half Highlights 35 8 YTD 2012 YTD 2013 Asset360 Signings Surgical Services Revenue $27.4 $24.1 YTD 2012 YTD 2013 + 14% Hospital Volumes

Financial Review 2nd Quarter 2013

Refer to Appendix for reconciliation of Gross Margin Pre-ASC 805 to Gross Margin & Historical Depreciation to Depreciation Medical Equipment Outsourcing RENTAL OF UHS-OWNED EQUIPMENT Supplemental (short-term) Long-Term Bariatrics: Suite of specialty equipment for obese patients Surgery: Suite of minimally invasive lasers RENTAL OF MANUFACTURER-OWNED EQUIPMENT ASSET360TM EQUIPMENT MANAGEMENT PROGRAM On-site management to drive better equipment utilization (UHS people, technology & processes) Trend Analysis Q2 2012 included $12.8 of recall gains. Absent this, Cash Gross Margin would be up 3%. Momentum in certain growth areas including Asset360™ and Surgical Services offset continued weak Peak Need Rental caused by ongoing weak hospital admissions and acuity levels * Includes recall gains of $0.0 and $12.8 for Q2 2013 and 2012, $0.0 and $15.4 for YTD June 2013 and 2012, and $3.2 for LTM 2013 (In millions) LTM 2013 2012 % Chg 2013 2012 % Chg 2013 Revenues 78.3 $ 75.1 $ 4.3% 160.3 $ 152.5 $ 5.1% 310.5 $ Cash Gross Margin Pre ASC 805* 45.4 57.0 -20.4% 94.6 106.4 -11.1% 185.4 $ % of Revenue 58.0% 75.9% 59.0% 69.8% 59.7% Historical Depreciation (19.3) (18.3) (38.2) (36.5) (76.6) $ Gross Margin Pre ASC 805* 26.1 $ 38.7 $ -32.6% 56.4 $ 69.9 $ -19.4% 108.8 $ % of Revenue 33.3% 51.5% 35.2% 45.8% 35.0% June YTD 2nd Quarter

 Technical and Professional Services TECHNICAL SERVICES Maintain & Repair Customer owned Equipment: Non-resident, response based/ scheduled Biomedical Services Manufacturer Services BIOMED360TM EQUIPMENT MAINTENANCE PROGRAM Customizable on-site biomedical services program Refer to Appendix for reconciliation of Gross Margin Pre-ASC 805 to Gross Margin & Historical Depreciation to Depreciation Trend Analysis Will be “lumpy” going forward with large BioMed360 signings and Manufacturer Services projects (In millions) LTM 2013 2012 % Chg 2013 2012 % Chg 2013 Revenues 21.9 $ 22.4 $ -2.0% 43.2 $ 42.5 $ 1.6% 82.8 $ Cash Gross Margin Pre ASC 805 5.3 5.6 -5.4% 9.7 10.1 -4.0% 20.1 $ % of Revenue 24.2% 25.2% 22.5% 23.7% 24.3% Historical Depreciation (0.2) (0.1) (0.3) (0.3) (0.9) $ Gross Margin Pre ASC 805 5.1 $ 5.5 $ -6.1% 9.4 $ 9.8 $ -4.8% 19.2 $ % of Revenue 23.4% 24.5% 21.7% 23.1% 23.2% 2nd Quarter June YTD

 Medical Equipment Sales and Remarketing ASSET RECOVERY & EQUIPMENT BROKERAGE NEW EQUIPMENT SALES DISPOSABLE SALES Refer to Appendix for reconciliation of Gross Margin Pre-ASC 805 to Gross Margin & Historical Depreciation to Depreciation Trend Analysis Results in this segment will fluctuate based on equipment availability, transactional size and the transactional nature of the business (In millions) LTM 2013 2012 % Chg 2013 2012 % Chg 2013 Revenues 6.8 $ 9.3 $ -26.9% 13.9 $ 15.6 $ -11.2% 28.6 $ Cash Gross Margin Pre ASC 805 1.5 2.0 -25.0% 3.0 3.7 -18.9% 6.4 $ % of Revenue 22.1% 21.8% 21.6% 23.8% 22.4% Historical Depreciation (0.1) (0.1) (0.2) (0.2) (0.4) $ Gross Margin Pre ASC 805 1.4 $ 1.9 $ -26.0% 2.8 $ 3.5 $ -19.6% 6.0 $ % of Revenue 21.0% 20.7% 20.4% 22.6% 21.0% 2nd Quarter June YTD

Selected Financial Data * Includes recall gains of $0.0 and $12.8 for Q2 2013 and 2012, $0.0 and $15.4 for YTD June 2013 and 2012, and $3.2 for LTM 2013 (In millions) LTM 2013 2012 % Chg 2013 2012 % Chg 2013 Consolidated Revenues 107.0 $ 106.7 $ 0.3% 217.3 $ 210.6 $ 3.2% 421.9 $ Cash Gross Margin Pre-ASC 805* 52.2 64.6 -19.2% 107.3 120.2 -10.8% 211.9 % of Revenues 48.8% 60.5% 49.4% 57.1% 50.2% Historical Depreciation (19.6) (18.5) (38.7) (37.0) (77.9) Gross Margin Pre-ASC 805 32.6 46.1 -29.3% 68.6 83.2 -17.6% 134.0 % of Revenues 30.5% 43.2% 31.6% 39.5% 31.8% Cash SG&A 23.6 22.0 7.3% 46.6 42.4 9.9% 87.4 % of Revenues 22.1% 20.6% 21.4% 20.1% 20.7% Non Controlling Interest 0.1 0.2 0.3 0.4 0.7 % of Revenues 0.1% 0.2% 0.1% 0.2% 0.2% Adjusted EBITDA* Actual 28.5 $ 42.4 $ -32.8% 60.4 $ 77.4 $ -22.0% 123.8 $ Memo: Recall Gains 12.8 $ 15.4 $ 3.2 $ 2nd Quarter June YTD

$235 Bank Line Liquidity Profile Remains Solid Borrowing Base = $202 (In millions) 7.625% Fixed Rate Notes $235 Revolver Additional Commitment = $37 Available Liquidity = ~ $159 Used = ~ $39 Borrowing Base = $198 Debt Maturities

 Cash Flow from Operations: (In millions) $17.7 $30.1 2013 2012 YTD Q2 ~ $4.0mm due to timing of interest payments ~ $3.0mm due change in lower interest rates due to prior year hedge coming off floaters Remainder represents favorable working capital

Leverage Trend *Does not include unamortized bond premium of $13.5 and $0.0 for 2013 and 2012. Refer to Appendix for reconciliation of Adjusted EBIDTA to Cash Flow from Operations and pro forma calculation Note that our calculations include accrued interest for conservatism (In millions) (In millions) 6/30/2013 12/31/2012 Floating Rate Notes - $ 230.0 $ Original Notes - 7.625% 425.0 425.0 Add-on Notes - 7.625% 220.0 - Bank Line 34.5 28.0 Consolidated Capital Leases 16.3 16.0 Subtotal Debt 695.8 699.0 Add: Accrued Interest 18.9 13.8 Total Debt & Interest* 714.7 $ 712.8 $ Adjusted EBITDA 123.8 $ 141.3 $ Leverage* 5.8 5.0 UHS Debt Structure

2011 2012 2013 E Adjusted EBITDA Base: $118.0 Recall: $15.4 Total: $133.4 Pro forma: 136.8* Base: $122.2 Recall: $18.6 Total: $140.8 Pro forma: 141.3* $130 + / - (Recall: $0) Accrual CAPEX $80.2 $55.4 $70 + / - Year-end Leverage 4.9x* 5.0x* Upper 5’s Street Guidance for 2013 * Refer to later slide for pro forma calculations (In millions)

EBITDA Reconciliation: 2013 & 2012 EBITDA Reconciliation: 2004 – 2013 Selected Reconciliations Gross Margin Pre-ASC 805 to Gross Margin Depreciation and Amortization Reconciliation Other Reconciliations Appendix

EBITDA Reconciliation Adjusted EBITDA Reconciliation. Adjusted EBITDA is defined by UHS as Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”), before management, board and strategic fees, stock option expense, reorganization costs, ASC 805 impact, loss on extinguishment of debt, transaction and related costs and other. In addition to using Adjusted EBITDA internally as a measure of operational performance, we disclose Adjusted EBITDA externally to assist analysts, investors and lenders in their comparisons of operational performance, valuation and debt capacity across companies with differing capital, tax and legal structures. Management also understands that some industry analysts and investors consider Adjusted EBITDA as a supplementary non-GAAP financial measure useful in analyzing a company’s ability to service debt. Adjusted EBITDA, however, is not a measure of financial performance under Generally Accepted Accounting Principals (“GAAP”) and should not be considered as an alternative to, or more meaningful than, net income as a measure of operating performance or to cash flows from operating, investing or financing activities or as a measure of liquidity. Since Adjusted EBITDA is not a measure determined in accordance with GAAP and is thus susceptible to varying interpretations and calculations, Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. Adjusted EBITDA does not represent an amount of funds that is available for management’s discretionary use. A reconciliation of consolidated net income (loss) to EBITDA and Adjusted EBITDA is included below. * Includes recall gains of $0.0 and $12.8 for Q2 2013 and 2012, $0.0 and $15.4 for YTD June 2013 and 2012, and $3.2 for LTM 2013 (In millions) LTM 2013 2012 2013 2012 2013 Net income (loss) attributable to UHS* (12.8) $ 2.1 $ (23.2) $ (1.0) $ (57.1) $ Interest expense 13.9 14.5 27.8 30.0 53.5 Provision (benefit) for income taxes 0.2 0.2 0.9 (3.0) 1.0 Depreciation and amortization 24.7 24.0 48.8 47.6 97.9 EBITDA* 26.0 40.8 54.3 73.6 95.3 Management, board & strategic fees 1.9 0.5 3.3 1.5 4.6 Loss on extinguishment of debt - - 1.9 - 14.2 Reorganization costs 0.2 - 0.3 - 7.3 Stock option expense 0.4 1.1 0.6 2.2 2.4 Other ASC 805 Impact - - - 0.1 - Adjusted EBITDA* 28.5 $ 42.4 $ 60.4 $ 77.4 $ 123.8 $ June YTD 2nd Quarter

EBITDA Reconciliation: 2004 – 2013 * Includes recall gains of $4.4, $15.4 and $18.6 for 2010, 2011, and 2012 LTM Q2 (In millions) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Net Cash provided by Operating Activities 38.0 $ 44.0 $ 48.9 $ 29.8 $ 56.2 $ 56.0 $ 76.2 $ 57.7 $ 72.5 $ 85.1 $ Changes in Operating Assets and Liabilities 2.2 2.3 0.7 6.7 3.6 6.2 (2.1) 0.6 (10.5) (27.6) Other and Non-Cash Expenses (3.4) (3.3) (4.1) (28.5) 6.5 6.3 (11.5) 15.9 (0.5) (16.7) Income Tax Expense 1.2 0.8 0.6 (9.7) (15.4) (11.5) 1.7 (8.3) (2.6) 1.0 Interest Expense 30.5 31.1 31.6 40.2 46.9 46.5 46.5 55.0 55.7 53.5 EBITDA* 68.5 74.9 77.7 38.5 97.8 103.5 110.8 120.9 114.6 95.3 Recapitalization, company sale, stock compensation and severance expenses - - - 27.2 - - - - - - Loss on extinguishment of debt - - - 23.4 - - - - 12.3 14.2 Financing and Reorganization Charges - - - 50.6 - - - - 12.3 14.2 Management, board & strategic fees 0.7 0.8 1.6 1.0 1.3 1.3 2.4 7.3 2.8 4.6 Reorganization costs - - - - - - - - 7.0 7.3 Stock option expense - - 1.7 3.7 2.5 1.3 7.3 4.3 4.0 2.4 ASC 805 impact - - - 2.4 2.3 2.0 1.1 0.9 0.1 - Other - - - (0.7) 0.1 - - - - - Adjusted EBITDA* 69.2 $ 75.7 $ 81.0 $ 95.5 $ 104.0 $ 108.1 $ 121.6 $ 133.4 140.8 123.8 Surgical Services LTM pro forma EBITDA 3.4 0.5 Pro forma Adjusted EBITDA 136.8 $ 141.3 $ Total Revenue 199.6 $ 215.9 $ 225.1 $ 264.0 $ 289.1 $ 297.2 $ 312.1 $ 355.2 $ 415.3 $ 421.9 $ Total Debt & Accrued Int, Less Cash & Investments 301.9 $ 305.0 $ 315.0 $ 501.1 $ 521.7 $ 522.3 $ 528.6 $ 674.8 $ 712.8 $ 728.2 $ Leverage (Total Net Debt & Accrued Interest Less Cash & Investments/ LTM adj EBITDA) 4.4 4.0 3.9 5.2 5.0 4.8 4.3 4.9 5.0 5.9

Selected Reconciliations (In millions) LTM 2013 2012 2013 2012 2013 Gross Margin ASC 805 Impact Depreciation 0.3 $ 0.1 $ 0.5 $ 0.2 $ 1.2 $ Total Gross Margin ASC 805 Impact 0.3 0.1 0.5 0.2 1.2 SG&A per GAAP to Cash SG&A SG&A per GAAP 30.9 29.0 62.3 56.6 134.7 Management, Board, & Strategic Fees (1.9) (0.5) (3.3) (1.5) (4.6) Loss on extinguishment of debt - - (1.9) - (14.2) Reorganization costs (0.2) - (0.3) - (7.3) Stock Option Expense (0.4) (1.1) (0.6) (2.2) (2.4) Other ASC 805 Impact - - - (0.1) - Historical Depreciation & Amortization (1.3) (1.5) (2.5) (2.3) (4.8) ASC 805 Depreciation & Amortization (3.5) (3.9) (7.1) (8.1) (14.0) Adjusted Cash SG&A 23.6 $ 22.0 $ 46.6 $ 42.4 $ 87.4 $ 2nd Quarter June YTD

Selected Reconciliations: Gross Margin Pre-ASC 805 to Gross Margin (In millions) 2nd Quarter LTM 2013 2012 2012 2012 2013 Medical Equipment Outsourcing Gross Margin Pre-ASC 805 26.1 $ 38.7 $ 56.4 $ 69.9 $ 108.8 $ ASC 805 Outsourcing Depreciation 0.3 0.1 0.5 0.2 1.2 Gross Margin per GAAP 25.8 38.6 55.9 69.7 107.6 Technical & Professional Services Gross Margin Pre-ASC 805 5.1 5.5 9.4 9.8 19.2 Gross Margin per GAAP 5.1 5.5 9.4 9.8 19.2 Medical Equipment Sales & Remarketing Gross Margin Pre-ASC 805 1.4 1.9 2.8 3.5 6.0 Gross Margin per GAAP 1.4 1.9 2.8 3.5 6.0 Total Gross Margin Pre-ASC 805 32.6 46.1 68.6 83.2 134.0 Total ASC 805 Depreciation 0.3 0.1 0.5 0.2 1.2 Total Gross Margin per GAAP 32.3 $ 46.0 $ 68.1 $ 83.0 $ 132.8 $ June YTD

Depreciation & Amortization Reconciliations (In millions) LTM 2013 2012 2013 2012 2013 Historical Outsourcing Depreciation 19.3 $ 18.3 $ 38.2 $ 36.5 $ 76.6 $ ASC 805 Outsourcing Depreciation 0.3 0.1 0.5 0.2 1.2 Total Outsourcing Depreciation 19.6 18.4 38.7 36.7 77.8 Historical Technical & Professional Services Depreciation 0.2 0.1 0.3 0.3 0.9 Total Technical & Professional Services Depreciation 0.2 0.1 0.3 0.3 0.9 Historical Sales & Remarketing Depreciation 0.1 0.1 0.2 0.2 0.4 Total Sales & Remarketing Depreciation 0.1 0.1 0.2 0.2 0.4 Historical Gross Margin Depreciation 19.6 18.5 38.7 37.0 77.9 Gross Margin ASC 805 Depreciation 0.3 0.1 0.5 0.2 1.2 Total Gross Margin Depreciation 19.9 18.6 39.2 37.2 79.1 Historical Selling, General, and Admin Depreciation 1.3 1.5 2.5 2.3 4.8 Total Selling, General, and Admin Depreciation 1.3 1.5 2.5 2.3 4.8 Total ASC 805 Selling, General, and Admin Amortization 3.5 3.9 7.1 8.1 14.0 Total Depreciation and Amortization 24.7 $ 24.0 $ 48.8 $ 47.6 $ 97.9 $ June YTD 2nd Quarter

Other Reconciliations LTM (In millions) 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Cash used in Investing Activities 65.2 $ 40.6 $ 51.7 $ 418.9 $ 71.4 $ 50.6 $ 74.2 $ 153.2 $ 73.6 $ 62.8 $ - Acquisitions (15.1) (1.1) - (349.7) - - - (70.0) (14.4) (2.6) - / + Other - - - 1.4 - 1.5 3.3 - - - - ME in A/P prior period (10.5) (3.8) (5.8) (7.4) (9.0) (5.7) (4.7) (11.8) (8.8) (5.0) + ME in A/P current period 3.8 5.8 7.4 9.0 5.7 4.7 11.8 8.8 5.0 8.0 Accrual CAPEX 43.4 $ 41.5 $ 53.3 $ 72.2 $ 68.1 $ 51.1 $ 84.6 $ 80.2 $ 55.4 $ 63.2 $ Certain Intellamed Assets - $ - $ - $ (14.6) $ - $ - $ - $ - $ - $ - $ UHS by Parent - - - (335.1) - - - - - - Emergent, net of cash received - - - - - - - (58.5) - - SLS, net of cash received - - - - - - - - (11.4) - Epic Rogue, net of cash received - - - - - - - - (2.6) (2.6) Other (15.1) (1.1) - - - - - (11.5) (0.4) - Total Acquisitions (15.1) $ (1.1) $ - $ (349.7) $ - $ - $ - $ (70.0) $ (14.4) $ (2.6) $ ACCRUAL CAPEX RECONCILIATION ACQUISITIONS